Hypomagnesaemic tetany associated with repeated courses of intravenous tobramycin in a patient with cystic fibrosis

被引：6
|
作者：
Adams, JP [1 ]
Conway, SP [1 ]
Wilson, C [1 ]
机构：
[1] Seacroft Hosp, Reg Adult Cyst Fibrosis Ctr, Leeds LS14 6UH, W Yorkshire, England
来源：
RESPIRATORY MEDICINE | 1998年 / 92卷 / 03期
关键词：
D O I：
10.1016/S0954-6111(98)90319-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：602 / 604
页数：3
相关论文
共 50 条
  • [41] A REAL WORLD ASSESSMENT OF PATIENT EXPERIENCE WITH TOBRAMYCIN INHALATION POWDER (TIP) AMONG PATIENTS WITH CYSTIC FIBROSIS
    Greenberg, J.
    Palmer, J.
    Chan, W.
    Correia, C.
    Whalley, D.
    Shannon, P.
    Sawicki, G. S.
    PEDIATRIC PULMONOLOGY, 2014, 49 : 377 - 377
  • [42] Pharmacokinetic modelling of intravenous tobramycin in adolescent and adult patients with cystic fibrosis using the nonparametric expectation maximization (NPEM) algorithm
    D.J. Touw
    A.A.T.M.M. Vinks
    C. Neef
    Pharmacy World and Science, 1997, 19 : 142 - 151
  • [43] Tobramycin Once- vs Thrice-Daily for Elective Intravenous Antipseudomonal Therapy in Pediatric Cystic Fibrosis Patients
    Riethmueller, J.
    Ballmann, M.
    Schroeter, T. W.
    Franke, P.
    von Butler, R.
    Claass, A.
    Junge, S.
    Doering, G.
    Stern, M.
    INFECTION, 2009, 37 (05) : 424 - 431
  • [44] Pharmacokinetic modelling to predict risk of ototoxicity with intravenous tobramycin treatment in cystic fibrosis (vol 76, pg 2023, 2021)
    Dong, Min
    Rodriguez, Anna, V
    Blankenship, Chelsea M.
    McPhail, Gary
    Vinks, Alexander A.
    Hunter, Lisa L.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (05) : 1201 - 1201
  • [45] Tobramycin once- vs thrice-daily for elective intravenous antipseudomonal therapy in pediatric cystic fibrosis patients
    J. Riethmueller
    M. Ballmann
    T. W. Schroeter
    P. Franke
    R. von Butler
    A. Claass
    S. Junge
    G. Doering
    M. Stern
    Infection, 2009, 37 : 424 - 431
  • [46] Pharmacokinetic modelling of intravenous tobramycin in adolescent and adult patients with cystic fibrosis using the nonparametric expectation maximization (NPEM) algorithm
    Touw, DJ
    Vinks, AATMM
    Neef, C
    PHARMACY WORLD & SCIENCE, 1997, 19 (03): : 142 - 151
  • [47] SAFETY AND EFFICACY OF A HYDRATION PROTOCOL FOR PEDIATRIC PATIENTS WITH CYSTIC FIBROSIS RECEIVING INTRAVENOUS, EXTENDED-INTERVAL DOSING TOBRAMYCIN
    Vejzovic, J.
    Beagle, A.
    Starner, T.
    PEDIATRIC PULMONOLOGY, 2018, 53 : 277 - 277
  • [48] Pandoraea bacteremia in a cystic fibrosis patient with associated systemic illness
    Johnson, LN
    Han, JY
    Moskowitz, SM
    Burns, JL
    Qin, X
    Englund, JA
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (09) : 881 - 882
  • [49] Gaps in Cystic Fibrosis Care Are Associated with Reduced Lung Function in the US Cystic Fibrosis Foundation Patient Registry
    Sears, Edmund H., Jr.
    Hinton, Alexandra C.
    Lopez-Pintado, Sara
    Lary, Christine W.
    Zuckerman, Jonathan B.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2023, 20 (09) : 1250 - 1257
  • [50] CYSTIC FIBROSIS TOBRAMYCIN-RELATED INTRA- AND INTER-PATIENT VARIABILITY: THE CF ON TRIAL STUDY
    Seaman, S. M.
    Droege, C.
    Ernst, N.
    Winter, J.
    Foertsch, M.
    McCrory, B. E.
    Yasuda, M.
    Mueller, E.
    Joseph, P.
    PEDIATRIC PULMONOLOGY, 2015, 50 : 340 - 340
12345